Revolution Medicines (RVMD) EBIT (2019 - 2026)
Revolution Medicines' EBIT was -$505.13 million in Q2 2026, compared with -$264.71 million a year earlier.
Powered by 
Analysis
Revolution Medicines (RVMD) EBIT (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Revolution Medicines' EBIT was -$1.63 billion through Jun 30, 2026; for FY2025, it was -$1.18 billion.
- In earlier years, EBIT was -$689.52 million in FY2024, -$487.19 million in FY2023, -$258.28 million in FY2022 and -$188.01 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly EBIT in data going back to Q1 2019.
- Per Business Quant data, RVMD's EBIT in the three quarters before Q2 2026 was -$445.22 million (Q1 2026), -$361.63 million (Q4 2025) and -$315.27 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,221.09 Bn | 1,194.71 Bn | 20.46 Bn | 12.79 Bn |
| 2 | Johnson & Johnson | 656.38 Bn | 576.24 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 510.79 Bn | 478.80 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 363.00 Bn | 317.38 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 313.89 Bn | 287.12 Bn | - | - |
| 6 | Astrazeneca | 290.02 Bn | 263.91 Bn | 13.26 Bn | 4.39 Bn |
| 7 | Amgen | 249.59 Bn | 204.98 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 208.15 Bn | 183.26 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 170.74 Bn | 118.10 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Revolution Medicines | 38.00 Bn | 28.20 Bn | - | -505.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -505.13 Mn |
| Mar 31, 2026 | -445.22 Mn |
| Dec 31, 2025 | -361.63 Mn |
| Sep 30, 2025 | -315.27 Mn |
| Jun 30, 2025 | -264.71 Mn |
| Mar 31, 2025 | -240.76 Mn |
| Dec 31, 2024 | -216.31 Mn |
| Sep 30, 2024 | -175.71 Mn |
| Jun 30, 2024 | -156.64 Mn |
| Mar 31, 2024 | -140.86 Mn |
| Dec 31, 2023 | -179.98 Mn |
| Sep 30, 2023 | -123.25 Mn |
| Jun 30, 2023 | -108.80 Mn |
| Mar 31, 2023 | -75.16 Mn |
| Dec 31, 2022 | -61.71 Mn |
| Sep 30, 2022 | -76.53 Mn |
| Jun 30, 2022 | -62.09 Mn |
| Mar 31, 2022 | -57.95 Mn |
| Dec 31, 2021 | -52.91 Mn |
| Sep 30, 2021 | -53.16 Mn |
API Access
Revolution Medicines EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();